首页> 美国卫生研究院文献>ISRN Oncology >Differentiated Thyroid Cancer in Navarra (Spain): Historic Cohort Results (1987–2003)
【2h】

Differentiated Thyroid Cancer in Navarra (Spain): Historic Cohort Results (1987–2003)

机译:纳瓦拉(西班牙)的甲状腺癌分化:历史队列结果(1987–2003年)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction. Navarra has the highest incidence of differentiated thyroid cancer in Spain. The aim of this study was to review its management carried out by the Navarra's multidisciplinary Thyroid Disease Unit, from 1987 to 2003. Material and Methods. 325 patients were studied to find the incidence, prevalence, and prognostic factors. Statistical analysis comprised univariate and multivariate Cox proportional hazards regression models for survival and tumor recurrence. Results. The average annual incidence was 3.6 per 100,000 inhabitants, with a final prevalence of 82.4 per 100,000. Regarding survival and recurrence, statistical significance was observed for stage IV, follicular carcinoma, capsular and prethyroid muscles invasion, and T4 group. Only survival was related to tumour size larger than 40 mm. Only recurrence was related to lymph node metastases and radioiodine dose higher than 100 mCi. Conclusions. Attendance of patients in a functional unit setting has allowed us to classify them into three risk groups.
机译:介绍。在西班牙,纳瓦拉(Navarra)的分化型甲状腺癌发病率最高。这项研究的目的是回顾Navarra的多学科甲状腺疾病科在1987年至2003年间所进行的管理。材料与方法。对325例患者进行了研究,以发现其发病率,患病率和预后因素。统计分析包括生存和肿瘤复发的单变量和多变量Cox比例风险回归模型。结果。年平均发病率为每10万居民3.6个,最终患病率为每10万居民82.4个。关于存活和复发,IV期,滤泡癌,包膜和甲状腺前肌浸润以及T4组具有统计学意义。只有存活与肿瘤大小大于40mm有关。仅复发与淋巴结转移和放射性碘剂量高于100 mCi有关。结论。功能单元设置中的患者出勤率使我们可以将他们分为三个风险组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号